Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Embryonic stem cells: a perspective.

Martin Evans1

  • 1Cardiff School of Biosciences, Cardiff University, PO Box 911, Cardiff CF10 3US, UK.

Novartis Foundation Symposium
|July 30, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Craniofacial Collaboration UK: Long-Term Developmental Outcomes of Single Suture Craniosynostosis.

The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association·2026
Same author

Estimating changes in facility MRSA infection rates due to changes in MRSA precaution policy.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Comparative cohort study of post-acute COVID-19 infection with a nested, randomized controlled trial of ivabradine for those with postural orthostatic tachycardia syndrome (the COVIVA study).

Frontiers in neurology·2025
Same author

Gully erosion is a serious obstacle in India's land degradation neutrality mission.

Scientific reports·2025
Same author

A cross-sectional survey of Department of Veterans Affairs laboratory practices for identification of carbapenem-resistant <i>Acinetobacter baumannii</i> and <i>Pseudomonas aeruginosa</i>.

Antimicrobial stewardship & healthcare epidemiology : ASHE·2024
Same author

Tambjamines as Fast-Acting Multistage Antimalarials.

ACS infectious diseases·2024

Embryonic stem (ES) cells, derived from early mammalian embryos, possess remarkable differentiation potential. Research explores their use in genetic engineering and regenerative medicine, though ethical considerations for human applications persist.

Area of Science:

  • Developmental Biology
  • Stem Cell Biology
  • Regenerative Medicine

Background:

  • Embryonic stem (ES) cells are undifferentiated cells with pluripotency, mirroring the early mammalian embryo's potential.
  • While mouse ES cells are well-characterized, similar cell lines have been established from other mammals, including humans.
  • ES cells can differentiate in vivo and in vitro, offering significant research and therapeutic possibilities.

Purpose of the Study:

  • To review the characteristics and potential applications of embryonic stem cells.
  • To discuss the utility of ES cells in mammalian genetic engineering.
  • To explore the prospects of human ES cells in cellular and tissue engineering therapies.

Main Methods:

  • Review of existing literature on embryonic stem cell research.

Related Experiment Videos

  • Analysis of differentiation capabilities in vitro and in vivo.
  • Discussion of genetic engineering applications and therapeutic potential.

    • Main Results:

    • Embryonic stem cells exhibit extensive differentiation capacity, forming various tissue precursors.
    • Their genetic manipulability in vitro makes them valuable for mammalian genetic engineering (primarily in mice).
    • Human ES cells show promise for regenerative medicine but face ethical and practical challenges.

    Conclusions:

    • Embryonic stem cells hold significant potential for advancing genetic engineering and regenerative medicine.
    • Further research, particularly leveraging knowledge from mouse models, is crucial for understanding human ES cell biology and applications.
    • Ethical and practical hurdles must be addressed for the clinical implementation of human embryonic stem cell therapies.